A Safety and Tolerability Study of Jaktinib
Clinical trial NCT05279001 · UNKNOWN
Trial details
- NCT number
- NCT05279001
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-05-31
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.